Lot No. 30 Treprostinil B31

Auto-translated from Polish

Original title: Pakiet nr 30 Treprostinil B31

Szpital Specjalistyczny w Zabrzu Sp. z o.o.

Published: Sep 24, 2026

Updated: Sep 28, 2026

Source: TED - Tenders Electronic Daily (EU)

This tender has been awarded

Awarded to SALUS INTERNATIONAL Sp. z o.o. — PLN 879,060

Browse open Health & Medical tenders in Poland

About This Opportunity

This is a supplies contract in the health and medical services sector. Located in Poland, Europe, this opportunity is open to firms and consortiums, with an estimated budget of PLN 684,600.

Published through TED - Tenders Electronic Daily (EU), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.

Description

Auto-translated from Polish

Lot No. 30 Treprostinil B31. The detailed description of the subject of the order is Annex No. 3 to the SWZ – Assortment and Price Form. In accordance with Chapter III, point 3 of the SWZ: Subject conditions required from Contractors - Contractors submitting an offer in the proceedings declare that they undertake to comply with the following requirements: 1) They will offer medicinal products that meet the requirements specified in the Act of September 6, 2001, Pharmaceutical Law (Journal of Laws 2026.612 as of 2026.05.07), consistent with the description of the subject of the order contained in the Assortment and Price Forms constituting Annex No. 3 to the SWZ. 2) The Contractor has documents confirming that the products listed in the Assortment and Price Forms constituting Annex No. 3 to the SWZ are registered with the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products in accordance with the requirements of the Act of 06.09.2001 Pharmaceutical Law (Journal of Laws 2026.612 as of 2026.05.07). 3) For medicines in all lots 1-30, the Contracting Authority requires a valid permit from the Chief Pharmaceutical Inspectorate for trading in medicinal products. 4) Lots 1-30 contain biological medicines for treatment programs. The Contracting Authority requires that the medicines be approved for use and reimbursed under treatment programs. Currently, these are: 03.0000.331.02 (B31) Treatment of pulmonary arterial hypertension 03.0000.347.02 (B47) Treatment of moderate and severe plaque psoriasis 03.0000.407.02 (B 107) Treatment of chronic spontaneous urticaria 03.0000.556.02 (B156) Treatment of patients with nasal polyposis and sinusitis 03.0000.424.02 (B.124) Treatment of patients with severe atopic dermatitis 03.0000.374.02 (B74) Treatment of chronic thromboembolic pulmonary hypertension (CTEPH) 03.0000.401.02 (B 101) Treatment of familial hypercholesterolemia The Contracting Authority further requires that: A. The entire assortment consists of medicinal products. B. The Contractor will sign annexes to the agreements if the reimbursement for the duration of the agreement changes for products (with the same international name) that will be covered by such reimbursement. C. The price of the medicine, in the case of a medicine subject to an official price, must be consistent with the current official price of the given medicine on the day of order fulfillment throughout the entire contract period. In the event of a change in the financing rules for the purchase of medicines by the National Health Fund, reducing prices, or a reduction in the official price of the medicine below the price resulting from the Contractor's offer, an annex will be signed for the period of their validity. After this period, the price will revert to the price resulting from the Contractor's original tender offer, which is always the maximum price for the Contracting Authority. D. Transport of the product will be to the place indicated by the Contracting Authority in accordance with the requirements specified in the SmPC of the medicinal products. E. The Contractor will provide the Summary of Product Characteristics (SmPC) or its equivalent translation into Polish (LOTS 1-30) with the offer. 5) The Contractor will ensure, at their own cost and risk, the transport of medicinal products to the place indicated by the Contracting Authority. The transport of all medicinal products will be carried out in accordance with the requirements specified in the current documents confirming the market authorization and use of the subject of the order in accordance with the Act of September 6, 2001, Pharmaceutical Law (Journal of Laws 2026.612 as of 2026.05.07) and the Regulation of the Minister of Health of October 22, 2022, on the basic conditions for running a pharmacy (Journal of Laws 2025.1579) as amended by the Regulation of the Minister of Health of November 17, 2025, amending the regulation on the basic conditions for running a pharmacy. The Contracting Authority has the right to inspect the means of transport used to transport medicinal products for the presence of temperature records in the transport chamber and the presence of pallets on which boxes with medicinal products are transported. In case of non-compliance with transport requirements specified in the current documents confirming the market authorization...

Data provenance

This notice is sourced from TED - Tenders Electronic Daily (EU) and was originally published on September 24, 2026. Last refreshed 5 days ago. Original language: Polish. BidsFactory mirrors official procurement notices and links back to the source for full legal text.

About Szpital Specjalistyczny w Zabrzu Sp. z o.o.

Szpital Specjalistyczny w Zabrzu Sp. z o.o. has issued 14 procurement notices on BidsFactory, including 0 currently open and 8 awarded contracts. Activity concentrates in Health & Medical and General Supplies & Services. All notices are published for Poland. Notices are distributed via TED - Tenders Electronic Daily (EU). Most recent publication: September 28, 2026.

Frequently asked questions about this tender

Who is the contracting authority?

This notice was issued by Szpital Specjalistyczny w Zabrzu Sp. z o.o. in Poland. The authority is responsible for evaluating bids, awarding the contract, and managing performance.

What type of contract is this?

This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.

How much was the contract awarded for?

SALUS INTERNATIONAL Sp. z o.o. was awarded the contract for PLN 879,060. The figure reflects the value disclosed by the contracting authority in the award notice.

Where will the contract be performed?

The contract is for delivery in Poland. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.

How can I submit a bid?

Visit TED - Tenders Electronic Daily (EU) to access the full notice, required documents, and submission instructions provided by the contracting authority.

Is this tender still open?

No — the contract has already been awarded to SALUS INTERNATIONAL Sp. z o.o.. The award notice is archived on BidsFactory for transparency and market intelligence.